Lancet:药物预防心血管疾病和死亡的效果如何?降压越早越好!

2021-08-28 MedSci原创 MedSci原创

血压升高是众所周知的、可改变的心血管发病率和死亡率的危险因素,降压药物发挥着重要的心脏保护作用。

血压升高是众所周知的、可改变的血管发病率和死亡率的危险因素,降压药物发挥着重要的心脏保护作用。随着人口老龄化,降压药物治疗效果的一个日益重要的不确定因素是,是否应该在老年(70岁及以上)开始治疗,并持续到老年。

流行病学研究表明,血压升高是不同年龄段和不同血压范围内心血管事件的主要危险因素。尽管这些研究发现相对风险随着年龄的增长而有所降低,但因为心血管事件的绝对发生率随着年龄的增长而增加,老年患者从降压治疗中获得的收益可能与年轻人一样多,甚至更多。

然而,其他研究报告称,与血压较高的患者相比,血压较低的老年患者发生心血管事件和死亡的风险增加。有些人甚至认为在死亡前几年血压会迅速下降,这使人们对老年人降压治疗的价值产生怀疑。

到目前为止,随机对照试验(RCTs)还缺乏有力的证据,部分原因是老年人在临床试验中的代表性不足。迄今为止,老年高血压试验(HYVET)是唯一一个专门招募80岁及以上患者的大规模试验。这项研究发现中风风险降低了30%,心血管死亡风险降低了23%。

为了探讨药物降压对70岁及以上的人的心血管疾病的影响,特别是在血压没有大幅上升的情况下的影响,国际降压治疗试验者合作组织开展了一项研究,比较了降压治疗对按年龄和基线血压分层的患者群体中主要心血管事件风险的影响。结果发表在Lancet杂志上。

研究人员使用来自药物降压与安慰剂或其他类降压药物的随机对照试验数据进行了荟萃分析,每个治疗组至少有1000人-年的随访。以前有心衰病史的参与者被排除在外。研究人员们汇集了这些数据,并将参与者分为基线年龄组(<55岁,55-64岁,65-74岁,75-84岁,以及≥85岁)和血压类别(从收缩压<120到≥170mmHg,以及从收缩压<70到≥110 mmHg,以10 mmHg递增)。采用固定效应的单阶段方法,并应用Cox比例危险模型,按试验进行分层,对数据进行分析。主要结果被定义为致命或非致命的中风、致命或非致命的心肌梗死或缺血性心脏病、或导致死亡或需要住院的心力衰竭的综合结果。

研究人员纳入了来自51项随机临床试验的358707名参与者的数据。随机化时参与者的年龄从21岁到105岁不等(中位数65岁),其中42960人(12.0%)小于55岁,128437人(35.8%)55-64岁,128506人(35.8%)65-74岁,54016人(15.1%)75-84岁,以及4788人(1.3%)85岁以上。

按治疗分配和年龄类别分层, 收缩压每降低5mmHg的主要心血管事件发生率。

每个年龄组的收缩压每降低5mmHg发生主要心血管事件的危险在55岁以下的人中降低18%(HR=0.82, 95% CI 0.76-0.88)。而55-64岁、65-74、75-84和85岁以上则分别降低9%、9%、9%与1%(HR=0.91、0.91、0.91和0.99)。同样在舒张压降低3mmHg时也观察到类似的比例风险降低模式。此外,主要心血管事件的绝对风险降低因年龄而异,在老年组中更大。但并没有发现任何证据表明任何年龄组的不同基线血压类别的相对治疗效果具有临床意义的异质性。

药物降压对老年人有效,没有证据表明预防主要心血管事件的相对风险降低会因随机化时的收缩压或舒张压水平不同而不同,低至120/70mmHg以下。因此,无论年龄大小,药物降压都应被视为一种重要的治疗选择,国际指南中取消了与年龄有关的血压阈值。

 

参考文献:

Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis. https://doi.org/10.1016/S0140-6736(21)01921-8

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2022-04-22 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-29 fanhanwen0711

    降压要达标

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-28 病毒猎手

    #心血管##高血压#降压是常态,不论年龄大小

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-28 goodbing

    顶刊就是不一样,质量很高,内容精彩!学到很多

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1831284, encodeId=c11c18312847e, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Fri Apr 22 23:12:21 CST 2022, time=2022-04-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1292118, encodeId=d22e1292118bc, content=<a href='/topic/show?id=9d32981418b' target=_blank style='color:#2F92EE;'>#降压#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98141, encryptionId=9d32981418b, topicName=降压)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8f14236, createdName=经常头晕, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1498930, encodeId=3b9d1498930d4, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1542225, encodeId=3885154222594, content=<a href='/topic/show?id=d20a8e9073e' target=_blank style='color:#2F92EE;'>#药物预防#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87907, encryptionId=d20a8e9073e, topicName=药物预防)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7e3b13370459, createdName=ms6829001416292975, createdTime=Mon Aug 30 07:12:21 CST 2021, time=2021-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012571, encodeId=4e5710125e153, content=降压要达标, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=70f82992070, createdName=fanhanwen0711, createdTime=Sun Aug 29 15:29:08 CST 2021, time=2021-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1012380, encodeId=702c101238010, content=<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a><a href='/topic/show?id=1c1710265113' target=_blank style='color:#2F92EE;'>#高血压#</a>降压是常态,不论年龄大小, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51728, encryptionId=974e51e2810, topicName=心血管), TopicDto(id=102651, encryptionId=1c1710265113, topicName=高血压)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211210/ede9c51184aa4f54ae6c1164cfb8eeac/967dbf3eff2943c7bf3ccfec3a776ab0.JPG, createdBy=a33789389, createdName=病毒猎手, createdTime=Sat Aug 28 20:14:26 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1034435, encodeId=c8ab103443590, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047444, encodeId=eefa104e44452, content=疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Sat Aug 28 19:12:21 CST 2021, time=2021-08-28, status=1, ipAttribution=)]
    2021-08-28 CHANGE

    疗效只是效果的众多方面之一,还要看对患者的获益,包括生活质量等因素共同决定效果的

    0

相关资讯

Hypertension: β受体阻滞剂会引起抑郁吗?

这种对双盲随机对照试验大规模数据的分析并不支持β受体阻滞剂治疗与抑郁症之间的关联。

Hypertension:感染HIV的高血压患者降压药类别与心血管结局的关系

研究人员观察到HIV感染且伴有高血压的患者CVD的发生率很高,β受体阻滞剂用于初始高血压治疗的使用率很高,即使在没有适应症的患者中也是如此。

Neurology:血管紧张素 II 刺激型抗高血压药,或有助于预防痴呆

血管紧张素 II 刺激型抗高血压药,或有助于预防痴呆

Hypertension:青壮年高血压患者不坚持服用降压药有什么后果?

在开始降压药物治疗的青壮年中,服药依从性差与未来心血管疾病的风险较高相关。这项研究强调了青壮年尽早认真治疗高血压的重要性。

Hypertension:降压药与COVID-19风险

这项大型观察性研究可能表明,与CCBs相比,长期使用ACE抑制剂或ARBs治疗的高血压患者COVID-19风险更低。

拓展阅读

BMC Public Health:苏丹北部成年人打鼾与高血压和糖尿病相关

苏丹北部大约四分之一的成年人打鼾。打鼾在肥胖的成年人中更为常见,同时打鼾与高血压和2型糖尿病的发病率增加有关。

Circ Res 孤儿G蛋白偶联受体GPRC5C通过促进Ang II与AT1R的结合调节VSMC的收缩功能

该研究揭示了GPRC5C调节VSMCs收缩的作用机制,为高血压的治疗提供了新的靶点。

KARDIA-2 Ⅱ期研究公布主要结果:Zilebesiran联合其他口服药物,降压效果更佳! | ACC.24研究速递

KARDIA-2研究是一项Ⅱ期、随机、双盲、安慰剂对照研究,旨在评估Zilebesiran作为追加治疗(Add-on治疗)用于未控制高血压患者的疗效及安全性。

Hypertension:血浆甘氨酸和支链氨基酸之间的相互作用与高血压和冠心病有关

总支链氨基酸/甘氨酸比率是高血压和CHD代谢特征的关键因素,可能反映了甘氨酸和tBCAAs共享了生物学途径。

Hypertension:肾去神经支配术对高血压患者尿肽生物标志物的影响

根据2023年欧洲高血压指南,基于导管的肾去神经支配(RDN)被认为是未控制的高血压患者额外的治疗选择。RDN对与冠状动脉疾病相关的尿肽具有有益的作用。

Cardiovasc Diabetol:中性粒细胞与淋巴细胞的比值与高血压患者的全因死亡率和心血管死亡率相关

NLR升高独立地增加了高血压患者全因死亡和心血管死亡风险。